30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Albany Molecular Research Inc (AMRI)

Track

Stock chart
Ticker: AMRI Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
MADDALUNA ANTHONY J
1 purchase — total 24,986 USD
Buy 2 Dec 2016
Value US$4,811,275.04 | Price 297.79 | Shares 67,598
Sale 30 Nov 2016
Value US$2,953,709.68 | Price 156.25 | Shares 51,317
Sale 16 Nov 2016
Value US$102,000.00 | Price 17.00 | Shares 6,000
Sale 10 Nov 2016
Value US$13,180.15 | Price 16.79 | Shares 785
Sale 9 Aug 2016
Value US$21,421.29 | Price 15.29 | Shares 1,401
Sale 31 May 2016
Value US$72,050.00 | Price 14.41 | Shares 5,000
Buy 16 May 2016
Value US$160,750.00 | Price 12.86 | Shares 12,500
Buy 13 May 2016
Value US$160,250.00 | Price 12.82 | Shares 12,500
Sale 13 May 2016
Value US$30,149.97 | Price 12.77 | Shares 2,361
Sale 9 Nov 2015
Value US$980,000.00 | Price 19.60 | Shares 50,000
Sale 9 Nov 2015
Value US$980,000.00 | Price 19.60 | Shares 50,000
Sale 17 Aug 2015
Value US$20,450.00 | Price 20.45 | Shares 1,000
Sale 7 Aug 2015
Value US$105,300.00 | Price 21.06 | Shares 5,000
Sale 8 Jun 2015
Value US$99,950.00 | Price 19.99 | Shares 5,000
Buy 4 Jun 2015
Value US$199,800.00 | Price 19.98 | Shares 10,000
Sale 4 Jun 2015
Value US$15,409.46 | Price 19.58 | Shares 787
Sale 2 Jun 2015
Value US$72,712.50 | Price 19.39 | Shares 3,750
Sale 8 May 2015
Value US$144,000.00 | Price 19.20 | Shares 7,500
Sale 8 May 2015
Value US$135,450.00 | Price 19.35 | Shares 7,000
Sale 17 Mar 2015
Value US$64,855.00 | Price 18.53 | Shares 3,500
Sale 13 Mar 2015
Value US$8,286.39 | Price 18.79 | Shares 441
Sale 12 Mar 2015
Value US$91,100.00 | Price 18.22 | Shares 5,000
Sale 12 Mar 2015
Value US$91,300.00 | Price 18.26 | Shares 5,000
Sale 11 Mar 2015
Value US$13,194.30 | Price 18.30 | Shares 721
Buy 10 Mar 2015
Value US$177,200.00 | Price 17.72 | Shares 10,000
Buy 5 Mar 2015
Value US$354,000.00 | Price 17.70 | Shares 20,000
Sale 25 Feb 2015
Value US$80,850.00 | Price 16.17 | Shares 5,000
Sale 23 Feb 2015
Value US$60,825.00 | Price 16.22 | Shares 3,750
Sale 18 Feb 2015
Value US$20,575.00 | Price 16.46 | Shares 1,250
Sale 18 Feb 2015
Value US$62,250.00 | Price 16.60 | Shares 3,750
Sale 18 Feb 2015
Value US$26,747.04 | Price 16.48 | Shares 1,623
Planned sale 4 Dec 2014
Value US$166,262.23 | Price 16.00 | Shares 10,391
Sale 14 Nov 2014
Value US$168,630.00 | Price 16.06 | Shares 10,500
Sale 10 Nov 2014
Value US$127,725.00 | Price 17.03 | Shares 7,500
Buy 10 Nov 2014
Value US$510,300.00 | Price 17.01 | Shares 30,000
Sale 28 Aug 2014
Value US$24,675.00 | Price 19.74 | Shares 1,250
Sale 14 Aug 2014
Value US$197,600.00 | Price 19.76 | Shares 10,000
Sale 12 Aug 2014
Value US$571,500.00 | Price 19.05 | Shares 30,000
Sale 8 Aug 2014
Value US$189,900.00 | Price 18.99 | Shares 10,000
Sale 8 Aug 2014
Value US$15,135.03 | Price 18.99 | Shares 797
Sale 3 Jun 2014
Value US$42,325.00 | Price 16.93 | Shares 2,500
Sale 16 May 2014
Value US$19,312.50 | Price 15.45 | Shares 1,250
Buy 15 May 2014
Value US$156,000.00 | Price 15.60 | Shares 10,000
Sale 12 May 2014
Value US$38,175.00 | Price 15.27 | Shares 2,500
Buy 12 May 2014
Value US$462,000.00 | Price 15.40 | Shares 30,000
Sale 9 May 2014
Value US$37,000.00 | Price 14.80 | Shares 2,500
Sale 9 May 2014
Value US$13,275.60 | Price 14.80 | Shares 897
Sale 27 Feb 2014
Value US$79,750.00 | Price 15.95 | Shares 5,000
Sale 27 Feb 2014
Value US$47,190.00 | Price 15.73 | Shares 3,000
Sale 25 Feb 2014
Value US$37,975.00 | Price 15.19 | Shares 2,500
Sale 24 Feb 2014
Value US$225,000.00 | Price 15.00 | Shares 15,000
Sale 21 Feb 2014
Value US$22,305.00 | Price 14.87 | Shares 1,500
Sale 19 Feb 2014
Value US$20,055.00 | Price 13.37 | Shares 1,500
Sale 4 Dec 2013
Value US$27,325.00 | Price 10.93 | Shares 2,500
Buy 3 Dec 2013
Value US$322,500.00 | Price 10.75 | Shares 30,000
Buy 22 Nov 2013
Value US$231,400.00 | Price 11.57 | Shares 20,000
Sale 22 Nov 2013
Value US$26,565.00 | Price 11.55 | Shares 2,300
Buy 3 Jun 2013
Value US$102,300.00 | Price 10.23 | Shares 10,000
Sale 29 May 2013
Value US$9,008.00 | Price 11.26 | Shares 800
Sale 22 May 2013
Value US$82,275.00 | Price 10.97 | Shares 7,500
Sale 10 May 2013
Value US$12,480.00 | Price 10.40 | Shares 1,200
Sale 19 Mar 2013
Value US$2,556.78 | Price 9.91 | Shares 258
Sale 19 Mar 2013
Value US$1,783.80 | Price 9.91 | Shares 180
Sale 18 Mar 2013
Value US$2,554.88 | Price 9.98 | Shares 256
Sale 18 Mar 2013
Value US$2,485.02 | Price 9.98 | Shares 249
Sale 13 Mar 2013
Value US$9,107.88 | Price 10.69 | Shares 852
Sale 12 Mar 2013
Value US$7,277.75 | Price 10.75 | Shares 677
Sale 12 Mar 2013
Value US$7,460.50 | Price 10.75 | Shares 694
Sale 12 Mar 2013
Value US$11,481.10 | Price 10.73 | Shares 1,070
Sale 11 Mar 2013
Value US$36,264.50 | Price 10.25 | Shares 3,538
Sale 7 Mar 2013
Value US$9,560.00 | Price 9.56 | Shares 1,000
Sale 22 Feb 2013
Value US$8,049.12 | Price 8.18 | Shares 984
Sale 22 Feb 2013
Value US$8,049.12 | Price 8.18 | Shares 984
Sale 19 Feb 2013
Value US$7,890.00 | Price 7.89 | Shares 1,000
Buy 3 Dec 2012
Value US$50,000.00 | Price 5.00 | Shares 10,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-12-05 2016-12-02 B Purchase MADDALUNA ANTHONY J Non-Executive Director
67,598 +32.7%
297.79
US$4,811,275 		67,598 +32.7% 297.79 US$4,811,275
2016-12-01 2016-11-30 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
51,317 -8.5%
156.25
US$2,953,710 		51,317 -8.5% 156.25 US$2,953,710
2016-11-17 2016-11-16 S Sale HENDERSON LORI M.

SVP, Secretary & Gen Counsel

Officer
22,580 -10.8%
137.49
US$3,987,744 		22,580 -10.8% 137.49 US$3,987,744
2016-11-10 2016-11-10 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
785 -2.2%
16.79
US$13,180 		785 -2.2% 16.79 US$13,180
2016-08-10 2016-08-09 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
1,401 -3.7%
15.29
US$21,421 		1,401 -3.7% 15.29 US$21,421
2016-06-01 2016-05-31 S Sale OCONNOR KEVIN Non-Executive Director
5,000 -9.4%
14.41
US$72,050 		5,000 -9.4% 14.41 US$72,050
2016-05-16 2016-05-16 B Purchase Marth William S

President and CEO

Executive Director
12,500 +2.4%
12.86
US$160,750 		12,500 +2.4% 12.86 US$160,750
2016-05-16 2016-05-13 B Purchase Svokos George

Chief Operating Officer

Officer
12,500 +13.0%
12.82
US$160,250 		12,500 +13.0% 12.82 US$160,250
2016-05-16 2016-05-13 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
2,361 -5.9%
12.77
US$30,150 		2,361 -5.9% 12.77 US$30,150
2015-11-10 2015-11-09 S Sale D AMBRA CONSTANCE M Large shareholder
50,000 -2.1%
19.60
US$980,000 		50,000 -2.1% 19.60 US$980,000
2015-11-10 2015-11-09 S Sale D AMBRA THOMAS E

Chairman, Board of Directors

Non-Executive Director
50,000 -2.0%
19.60
US$980,000 		50,000 -2.0% 19.60 US$980,000
2015-08-17 2015-08-17 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
1,000 -3.4%
20.45
US$20,450 		1,000 -3.4% 20.45 US$20,450
2015-08-10 2015-08-07 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
5,000 -14.8%
21.06
US$105,300 		5,000 -14.8% 21.06 US$105,300
2015-06-09 2015-06-08 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
5,000 -14.8%
19.99
US$99,950 		5,000 -14.8% 19.99 US$99,950
2015-06-08 2015-06-04 B Purchase Marth William S

President and CEO

Executive Director
10,000 +2.3%
19.98
US$199,800 		10,000 +2.3% 19.98 US$199,800
2015-06-05 2015-06-04 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
787 -2.7%
19.58
US$15,409 		787 -2.7% 19.58 US$15,409
2015-06-04 2015-06-02 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
3,750 -11.3%
19.39
US$72,712 		3,750 -11.3% 19.39 US$72,712
2015-05-11 2015-05-08 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
7,500 -19.4%
19.20
US$144,000 		7,500 -19.4% 19.20 US$144,000
2015-05-11 2015-05-08 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
7,000 -18.3%
19.35
US$135,450 		7,000 -18.3% 19.35 US$135,450
2015-03-19 2015-03-17 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
3,500 -11.2%
18.53
US$64,855 		3,500 -11.2% 18.53 US$64,855
2015-03-16 2015-03-13 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
441 -1.4%
18.79
US$8,286 		441 -1.4% 18.79 US$8,286
2015-03-13 2015-03-12 S Sale OCONNOR KEVIN Non-Executive Director
5,000 -10.4%
18.22
US$91,100 		5,000 -10.4% 18.22 US$91,100
2015-03-13 2015-03-12 S Sale ROTH ARTHUR J Non-Executive Director
5,000 -11.2%
18.26
US$91,300 		5,000 -11.2% 18.26 US$91,300
2015-03-12 2015-03-11 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
721 -2.2%
18.30
US$13,194 		721 -2.2% 18.30 US$13,194
2015-03-11 2015-03-10 B Purchase Svokos George

Chief Commercial Officer

Officer
10,000 +16.5%
17.72
US$177,200 		10,000 +16.5% 17.72 US$177,200
2015-03-06 2015-03-05 B Purchase Marth William S

President and CEO

Executive Director
20,000 +5.1%
17.70
US$354,000 		20,000 +5.1% 17.70 US$354,000
2015-02-27 2015-02-25 S Sale Nolan Michael M

CFO

Officer
5,000 -6.8%
16.17
US$80,850 		5,000 -6.8% 16.17 US$80,850
2015-02-25 2015-02-23 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
3,750 -13.0%
16.22
US$60,825 		3,750 -13.0% 16.22 US$60,825
2015-02-20 2015-02-18 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
1,250 -4.7%
16.46
US$20,575 		1,250 -4.7% 16.46 US$20,575
2015-02-20 2015-02-18 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
3,750 -13.0%
16.60
US$62,250 		3,750 -13.0% 16.60 US$62,250
2015-02-20 2015-02-18 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
1,623 -6.1%
16.48
US$26,747 		1,623 -6.1% 16.48 US$26,747
2014-12-05 2014-12-04 PlS Planned sale CABLE STUART M Large shareholder
10,391 -0.3%
16.00
US$166,262 		10,391 -0.3% 16.00 US$166,262
2014-11-18 2014-11-14 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
10,500 -25.3%
16.06
US$168,630 		10,500 -25.3% 16.06 US$168,630
2014-11-12 2014-11-10 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
7,500 -19.5%
17.03
US$127,725 		7,500 -19.5% 17.03 US$127,725
2014-11-10 2014-11-10 B Purchase Marth William S

President and CEO

Executive Director
30,000 +9.6%
17.01
US$510,300 		30,000 +9.6% 17.01 US$510,300
2014-09-02 2014-08-28 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
1,250 -3.9%
19.74
US$24,675 		1,250 -3.9% 19.74 US$24,675
2014-08-14 2014-08-14 S Sale Nolan Michael M

SVP, CFO and Treasurer

Officer
10,000 -11.6%
19.76
US$197,600 		10,000 -11.6% 19.76 US$197,600
2014-08-13 2014-08-12 S Sale HENDERSON LORI M

SVP, Secretary & Gen. Counsel

Officer
30,000 -40.2%
19.05
US$571,500 		30,000 -40.2% 19.05 US$571,500
2014-08-12 2014-08-08 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
10,000 -24.4%
18.99
US$189,900 		10,000 -24.4% 18.99 US$189,900
2014-08-12 2014-08-08 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
797 -2.5%
18.99
US$15,135 		797 -2.5% 18.99 US$15,135
2014-06-04 2014-06-03 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
2,500 -7.3%
16.93
US$42,325 		2,500 -7.3% 16.93 US$42,325
2014-05-20 2014-05-16 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
1,250 -3.6%
15.45
US$19,312 		1,250 -3.6% 15.45 US$19,312
2014-05-16 2014-05-15 B Purchase Svokos George

SVP Sales & GM of API

Officer
10,000 +22.4%
15.60
US$156,000 		10,000 +22.4% 15.60 US$156,000
2014-05-13 2014-05-12 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
2,500 -7.0%
15.27
US$38,175 		2,500 -7.0% 15.27 US$38,175
2014-05-13 2014-05-12 B Purchase Marth William S

President and CEO

Executive Director
30,000 +10.6%
15.40
US$462,000 		30,000 +10.6% 15.40 US$462,000
2014-05-13 2014-05-09 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
2,500 -7.0%
14.80
US$37,000 		2,500 -7.0% 14.80 US$37,000
2014-05-13 2014-05-09 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
897 -2.6%
14.80
US$13,276 		897 -2.6% 14.80 US$13,276
2014-02-28 2014-02-27 S Sale ROTH ARTHUR J Non-Executive Director
5,000 -11.9%
15.95
US$79,750 		5,000 -11.9% 15.95 US$79,750
2014-02-27 2014-02-27 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
3,000 -7.9%
15.73
US$47,190 		3,000 -7.9% 15.73 US$47,190
2014-02-25 2014-02-25 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
2,500 -6.7%
15.19
US$37,975 		2,500 -6.7% 15.19 US$37,975
2014-02-25 2014-02-24 S Sale Nolan Michael M

VP, CFO and Treasurer

Officer
15,000 -16.5%
15.00
US$225,000 		15,000 -16.5% 15.00 US$225,000
2014-02-24 2014-02-21 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
1,500 -4.1%
14.87
US$22,305 		1,500 -4.1% 14.87 US$22,305
2014-02-19 2014-02-19 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
1,500 -4.0%
13.37
US$20,055 		1,500 -4.0% 13.37 US$20,055
2013-12-04 2013-12-04 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
2,500 -8.4%
10.93
US$27,325 		2,500 -8.4% 10.93 US$27,325
2013-12-04 2013-12-03 B Purchase Marth William S Non-Executive Director
30,000 +49.1%
10.75
US$322,500 		30,000 +49.1% 10.75 US$322,500
2013-11-22 2013-11-22 B Purchase Marth William S Non-Executive Director
20,000 +48.6%
11.57
US$231,400 		20,000 +48.6% 11.57 US$231,400
2013-11-22 2013-11-22 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
2,300 -7.7%
11.55
US$26,565 		2,300 -7.7% 11.55 US$26,565
2013-06-04 2013-06-03 B Purchase Marth William S Non-Executive Director
10,000 +35.3%
10.23
US$102,300 		10,000 +35.3% 10.23 US$102,300
2013-05-31 2013-05-29 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
800 -2.5%
11.26
US$9,008 		800 -2.5% 11.26 US$9,008
2013-05-23 2013-05-22 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
7,500 -11.6%
10.97
US$82,275 		7,500 -11.6% 10.97 US$82,275
2013-05-13 2013-05-10 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
1,200 -3.6%
10.40
US$12,480 		1,200 -3.6% 10.40 US$12,480
2013-03-20 2013-03-19 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
258 -0.4%
9.91
US$2,557 		258 -0.4% 9.91 US$2,557
2013-03-20 2013-03-19 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
180 -0.5%
9.91
US$1,784 		180 -0.5% 9.91 US$1,784
2013-03-20 2013-03-18 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
256 -0.4%
9.98
US$2,555 		256 -0.4% 9.98 US$2,555
2013-03-20 2013-03-18 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
249 -0.7%
9.98
US$2,485 		249 -0.7% 9.98 US$2,485
2013-03-13 2013-03-13 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
852 -1.5%
10.69
US$9,108 		852 -1.5% 10.69 US$9,108
2013-03-14 2013-03-12 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
677 -1.9%
10.75
US$7,278 		677 -1.9% 10.75 US$7,278
2013-03-13 2013-03-12 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
694 -1.2%
10.75
US$7,460 		694 -1.2% 10.75 US$7,460
2013-03-13 2013-03-12 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
1,070 -1.8%
10.73
US$11,481 		1,070 -1.8% 10.73 US$11,481
2013-03-13 2013-03-11 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
3,538 -5.5%
10.25
US$36,264 		3,538 -5.5% 10.25 US$36,264
2013-03-11 2013-03-07 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
1,000 -2.8%
9.56
US$9,560 		1,000 -2.8% 9.56 US$9,560
2013-02-26 2013-02-22 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
984 -2.7%
8.18
US$8,049 		984 -2.7% 8.18 US$8,049
2013-02-26 2013-02-22 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
984 -1.5%
8.18
US$8,049 		984 -1.5% 8.18 US$8,049
2013-02-21 2013-02-19 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
1,000 -2.6%
7.89
US$7,890 		1,000 -2.6% 7.89 US$7,890
2012-12-04 2012-12-03 B Purchase Marth William S Non-Executive Director
10,000 +80.3%
5.00
US$50,000 		10,000 +80.3% 5.00 US$50,000
Explore more

More insider trading research around Albany Molecular Research Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America